Results 221 to 230 of about 73,182 (252)
Some of the next articles are maybe not open access.
Markers for Anti-cytotoxic T-lymphocyte Antigen 4 (CTLA-4) Therapy in Melanoma
2013Therapeutic strategies that block Cytotoxic T lymphocyte antigen-4 (CTLA-4) enhance antitumor immunity and prolong the lives of patients with metastatic melanoma. However, only a subset of patients benefit, and responses are often delayed due to heterogeneous response kinetics.
Michael A, Postow +4 more
openaire +2 more sources
CTLA-4-dependent trogocytosis promotes the interactions between Tregs and antigen-presenting cells
The Journal of Immunology, 2020Abstract Regulatory T cells (Tregs) are responsible for the maintenance of immune homeostasis. They express the coinhibitory receptor CTLA-4 in high quantities, whose loss causes severe systemic autoinflammation in both mice and humans.
Murat Tekguc +4 more
openaire +1 more source
Identification of cytotoxic T-lymphocyte-associated antigen-4 (CTLA-4) isoforms in the Pekin duck
Developmental & Comparative Immunology, 2010Cytotoxic T-lymphocyte-associated antigen-4 (CTLA-4, CD152) is an inhibitory T cell receptor predominately expressed on activated T cells. The duck CTLA-4 (DuCTLA-4) cDNA and a transcript lacking the predicted transmembrane encoding region (DuCTLA-4DeltaTM) were isolated from splenocytes using RT-PCR.
Qingxia, Yao +6 more
openaire +2 more sources
The Role of CD28 and Cytotoxic T-Lymphocyte Antigen-4 (CTLA-4) in Regulatory T-Cell Biology
Immunological Reviews, 2006Summary: The profound influence of CD28 and cytotoxic T‐lymphocyte antigen‐4 (CTLA‐4) on T‐cell immunity has been known for over a decade, yet the precise roles played by these molecules still continue to emerge. Initially viewed as molecules that provide cell‐intrinsic costimulatory and inhibitory signals, recent evidence suggests that both CD28 and ...
Lucy Walker, David M Sansom
exaly +3 more sources
American Journal of Hematology, 2004
AbstractThe CTLA‐4 molecule plays an important role in immune regulation by downregulating activation of T cells. Polymorphisms in the CTLA‐4 gene have been shown to be associated to a number of autoimmune diseases including blood disorders. In this study, the intragenic polymorphisms of the CTLA‐4 gene at position −318*C/T, +49*A/G, and the ...
Giovanna Piras +2 more
exaly +3 more sources
AbstractThe CTLA‐4 molecule plays an important role in immune regulation by downregulating activation of T cells. Polymorphisms in the CTLA‐4 gene have been shown to be associated to a number of autoimmune diseases including blood disorders. In this study, the intragenic polymorphisms of the CTLA‐4 gene at position −318*C/T, +49*A/G, and the ...
Giovanna Piras +2 more
exaly +3 more sources
Critical Care Management of Chimeric Antigen Receptor T-Cell Therapy Recipients
Ca-A Cancer Journal for Clinicians, 2022Sandrine Valadè +2 more
exaly
Cytotoxic T lymphocyte antigen 4 (CTLA-4) dimorphism in patients with systemic lupus erythematosus.
Clinical and experimental rheumatology, 2000Genetic susceptibility to systemic lupus erythematosus (SLE) is conferred not only by various genes within the major histocompatibility complex (MHC) region, but also by several other non-MHC linked genes. The negatively signalling molecule CTLA-4 is involved in establishing and maintaining of peripheral T cell tolerance, which controls T cell ...
R, Pullmann +8 more
openaire +1 more source
A Review of Cancer Immunotherapy Toxicity
Ca-A Cancer Journal for Clinicians, 2020Lucy Boyce Kennedy
exaly

